{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:55:10Z","timestamp":1784868910002,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11596-024-2930-y","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T01:02:03Z","timestamp":1727398923000},"page":"1018-1025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predicts Cachexia and Prognosis in Hepatocellular Carcinoma Patients"],"prefix":"10.1007","volume":"44","author":[{"given":"Xin-xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-gui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"3","key":"2930_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021,71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"10127","key":"2930_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J, et al. Hepatocellular carcinoma. Lancet, 2018,391(10127):1301\u20131314","journal-title":"Lancet"},{"issue":"5","key":"2930_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11596-022-2620-6","volume":"42","author":"ZY Liu","year":"2022","unstructured":"Liu ZY, Kan XF, Zhang J, et al. Transarterial chemoembolization combined with apatinib for treatment of advanced hepatocellular carcinoma: analysis of survival and prognostic factors. Curr Med Sci, 2022,42(5):1015\u20131021","journal-title":"Curr Med Sci"},{"issue":"5","key":"2930_CR4","doi-asserted-by":"publisher","first-page":"e1157","DOI":"10.1016\/j.cgh.2021.09.022","volume":"20","author":"NE Rich","year":"2022","unstructured":"Rich NE, Phen S, Desai N, et al. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis. Clin Gastroenterol Hepatol, 2022,20(5):e1157\u2013e1169","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2930_CR5","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, et al. Cancer-associated cachexia. Nat Rev Dis Primers, 2018,4:17105","journal-title":"Nat Rev Dis Primers"},{"issue":"3\u20134","key":"2930_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11864-010-0127-z","volume":"11","author":"NB Kumar","year":"2010","unstructured":"Kumar NB, Kazi A, Smith T, et al. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol, 2010,11(3\u20134):107\u2013117","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"2930_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jcsm.12232","volume":"8","author":"JL Brown","year":"2017","unstructured":"Brown JL, Rosa-Caldwell ME, Lee DE, et al. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice. J Cachexia Sarcopenia Muscle, 2017,8(6):926\u2013938","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2930_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcsm.12402","volume":"10","author":"MS Anker","year":"2019","unstructured":"Anker MS, Holcomb R, Muscaritoli M, et al. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle, 2019,10(1):22\u201334","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"21","key":"2930_CR9","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.20.00611","volume":"38","author":"EJ Roeland","year":"2020","unstructured":"Roeland EJ, Bohlke K, Baracos VE, et al. Management of Cancer Cachexia ASCO Guideline. J Clin Oncol, 2020,38(21):2438\u20132453","journal-title":"J Clin Oncol"},{"issue":"5","key":"2930_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol, 2011,12(5):489\u2013495","journal-title":"Lancet Oncol"},{"issue":"1","key":"2930_CR11","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1038\/s41467-023-41952-w","volume":"14","author":"Y Kojima","year":"2023","unstructured":"Kojima Y, Mishiro-Sato E, Fujishita T, et al. Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia. Nat Commun, 2023,14(1):6246","journal-title":"Nat Commun"},{"issue":"7","key":"2930_CR12","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/ijms21072321","volume":"21","author":"G Fonseca","year":"2020","unstructured":"Fonseca GWPd, Farkas J, Dora E, et al. Cancer cachexia and related metabolic dysfunction. Int J Mol Sci, 2020,21(7):2321","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2930_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1139\/apnm-2019-0407","volume":"45","author":"ME Rosa-Caldwell","year":"2020","unstructured":"Rosa-Caldwell ME, Brown JL, Lee DE, et al. Hepatic alterations during the development and progression of cancer cachexia. Appl Physiol Nutr Metab, 2020,45(5):500\u2013512","journal-title":"Appl Physiol Nutr Metab"},{"key":"2930_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clnesp.2021.01.019","volume":"42","author":"PS Barcellos","year":"2021","unstructured":"Barcellos PS, Borges N, Torres DP. Resting energy expenditure in cancer patients: agreement between predictive equations and indirect calorimetry. Clin Nutr ESPEN, 2021,42:286\u2013291","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"2930_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jcsm.12869","volume":"13","author":"SE Kim","year":"2022","unstructured":"Kim SE, Kim DJ. Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle, 2022,13(1):8\u201310","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2930_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1148\/radiol.2019190734","volume":"294","author":"N Bastati","year":"2020","unstructured":"Bastati N, Beer L, Mandorfer M, et al. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease? Radiology, 2020,294(1):98\u2013107","journal-title":"Radiology"},{"issue":"11","key":"2930_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/RLI.0000000000000286","volume":"51","author":"N Bastati","year":"2016","unstructured":"Bastati N, Wibmer A, Tamandl D, et al. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters. Invest Radiol, 2016,51(11):728\u2013734","journal-title":"Invest Radiol"},{"issue":"4","key":"2930_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jhep.2022.04.032","volume":"77","author":"N Bastati","year":"2022","unstructured":"Bastati N, Beer L, Ba-Ssalamah A, et al. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD. J Hepatol, 2022,77(4):1005\u20131013","journal-title":"J Hepatol"},{"issue":"11","key":"2930_CR19","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1007\/s00330-021-07955-1","volume":"31","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Hong SB, Lee NK, et al. Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS. Eur Radiol, 2021,31(11):8606\u20138614","journal-title":"Eur Radiol"},{"issue":"1","key":"2930_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology, 2018,67(1):358\u2013380","journal-title":"Hepatology"},{"issue":"4","key":"2930_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/apt.15917","volume":"52","author":"NE Rich","year":"2020","unstructured":"Rich NE, Murphy CC, Yopp AC, et al. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther, 2020,52(4):701\u2013709","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"2930_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00330-024-10590-1","volume":"34","author":"S Poetter-Lang","year":"2024","unstructured":"Poetter-Lang S, Ambros R, Messner A, et al. Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study. Eur Radiol, 2024,34(8):1\u201313","journal-title":"Eur Radiol"},{"issue":"3","key":"2930_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1148\/radiol.2021204352","volume":"300","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Kim H, Lee DH, et al. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. Radiology, 2021,300(3):572\u2013582","journal-title":"Radiology"},{"key":"2930_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","volume":"127","author":"M Sadeghi","year":"2018","unstructured":"Sadeghi M, Keshavarz-Fathi M, Baracos V, et al. Cancer cachexia: Diagnosis, assessment, and treatment. Crit Rev Oncol Hematol, 2018,127:91\u2013104","journal-title":"Crit Rev Oncol Hematol"},{"key":"2930_CR25","doi-asserted-by":"publisher","first-page":"111271","DOI":"10.1016\/j.nut.2021.111271","volume":"90","author":"EVM Wiegert","year":"2021","unstructured":"Wiegert EVM, de Oliveira LC, Calixto-Lima L, et al. New cancer cachexia staging system for use in clinical practice. Nutrition, 2021,90:111271","journal-title":"Nutrition"},{"issue":"4","key":"2930_CR26","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00330-022-09226-z","volume":"33","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Wu HH, Zhao YF, et al. Abnormal [18F]FDG uptake in liver and adipose tissue: a potential imaging biomarker for cancer-associated cachexia. Eur Radiol, 2023,33(4):2561\u20132573","journal-title":"Eur Radiol"},{"issue":"8","key":"2930_CR27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/RLU.0000000000002658","volume":"44","author":"R Nakamoto","year":"2019","unstructured":"Nakamoto R, Okuyama C, Ishizu K, et al. Diffusely Decreased Liver Uptake on FDG PET and Cancer-Associated Cachexia With Reduced Survival. Clin Nucl Med, 2019,44(8):634\u2013642","journal-title":"Clin Nucl Med"},{"issue":"8","key":"2930_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1177\/02841851241261703","volume":"65","author":"XX Li","year":"2024","unstructured":"Li XX, Liu B, Zhao YF, et al. Predicting cachexia in hepatocellular carcinoma patients: a nomogram based on MRI features and body composition. Acta Radiol, 2024,65(8):898\u2013906","journal-title":"Acta Radiol"},{"issue":"2","key":"2930_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1148\/radiol.13122482","volume":"269","author":"D Feier","year":"2013","unstructured":"Feier D, Balassy C, Bastati N, et al. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging. Radiology, 2013,269(2):460\u2013468","journal-title":"Radiology"},{"issue":"7","key":"2930_CR30","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00261-022-03557-7","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan S, Eryuruk U, Tasdemir MN, et al. Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS. Abdom Radiol (NY), 2022,47(7):2325\u20132334","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"2930_CR31","doi-asserted-by":"publisher","first-page":"8764","DOI":"10.1007\/s00330-023-09950-0","volume":"33","author":"K Minamiguchi","year":"2023","unstructured":"Minamiguchi K, Irizato M, Uchiyama T, et al. Hepatobiliaryphase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review. Eur Radiol, 2023,33(12):8764\u20138775","journal-title":"Eur Radiol"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2930-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2930-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2930-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T23:11:45Z","timestamp":1733872305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2930-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2930-y","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}